Microbiota and probiotics: chances and challenges - a symposium report
- PMID: 39295904
- PMCID: PMC11406417
- DOI: 10.1017/gmb.2023.4
Microbiota and probiotics: chances and challenges - a symposium report
Abstract
The 10th International Yakult Symposium was held in Milan, Italy, on 13-14 October 2022. Two keynote lectures covered the crewed journey to space and its implications for the human microbiome, and how current regulatory systems can be adapted and updated to ensure the safety of microorganisms used as probiotics or food processing ingredients. The remaining lectures were split into sections entitled "Chances" and "Challenges." The "Chances" section explored opportunities for the science of probiotics and fermented foods to contribute to diverse areas of health such as irritable bowel syndrome, major depression, Parkinson's disease, immune dysfunction, infant colic, intensive care, respiratory infections, and promoting healthy longevity. The "Challenges" section included selecting appropriate clinical trial participants and methodologies to minimise heterogeneity in responses, how to view probiotics in the context of One Health, adapting regulatory frameworks, and understanding how substances of bacterial origin can cross the blood-brain barrier. The symposium provided evidence from cutting-edge research that gut eubiosis is vital for human health and, like space, the microbiota deserves further exploration of its vast potential.
Keywords: Parkinson’s disease; ageing; fermented foods; infancy; irritable bowel syndrome; probiotics.
© The Author(s) 2023.
Conflict of interest statement
Authors B.P. and C.K. are employees of Yakult Europe BV. while P.R. is an employee of Yakult Italy SrL. Author C.H.S.R. received financial support to draft this report. Speaker, Dr Larsen, is an employee of Yakult Nederland while speaker Dr Matsuda is an employee of the Yakult Central Institute, Yakult Honsha Co., Ltd., Japan.
Figures
Similar articles
-
The role of probiotics on the roadmap to a healthy microbiota: a symposium report.Gut Microbiome (Camb). 2020 Aug 26;1:e2. doi: 10.1017/gmb.2020.2. eCollection 2020. Gut Microbiome (Camb). 2020. PMID: 39296722 Free PMC article. Review.
-
"Gut" to grips with the science of the microbiome - a symposium report.Gut Microbiome (Camb). 2024 Nov 29;5:e11. doi: 10.1017/gmb.2024.8. eCollection 2024. Gut Microbiome (Camb). 2024. PMID: 39703540 Free PMC article.
-
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties.Microorganisms. 2024 Jan 23;12(2):234. doi: 10.3390/microorganisms12020234. Microorganisms. 2024. PMID: 38399637 Free PMC article. Review.
-
Probiotics: a proactive approach to health. A symposium report.Br J Nutr. 2015 Dec;114 Suppl 1:S1-15. doi: 10.1017/S0007114515004043. Br J Nutr. 2015. PMID: 26548336
-
Exploring the influence of the gut microbiota and probiotics on health: a symposium report.Br J Nutr. 2014 Jul;112 Suppl 1(Suppl 1):S1-18. doi: 10.1017/S0007114514001275. Br J Nutr. 2014. PMID: 24953670 Free PMC article.
Cited by
-
Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease.Gut Microbes. 2025 Dec;17(1):2486518. doi: 10.1080/19490976.2025.2486518. Epub 2025 Apr 10. Gut Microbes. 2025. PMID: 40207973 Free PMC article. Review.
-
Integrative review of the gut microbiome's role in pain management for orthopaedic conditions.World J Exp Med. 2025 Jun 20;15(2):102969. doi: 10.5493/wjem.v15.i2.102969. eCollection 2025 Jun 20. World J Exp Med. 2025. PMID: 40546666 Free PMC article. Review.
References
-
- Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K and Kunugi H (2016) Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. Journal of Affective Disorders 202, 254–257. - PubMed
-
- Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, Memarzadeh MR, Asemi Z and Esmaillzadeh A (2016) Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32(3), 315–320. - PubMed
-
- Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, MetaHIT Consortium, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M’rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD and Bork P (2011) Enterotypes of the human gut microbiome. Nature 473(7346), 174–180. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases